Biocryst Pharmaceuticals (BCRX) Q3 2026 Earnings

5AugConfirmed
Q3 2025
Q4 2025
Q2 2026
Q3 2026
-2.98
-1.89
-0.79
0.3

Details

Expected EPS
0.15418
Actual EPS
0.3
Surprise EPS
0.15
Surprise Percent
+94.58%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of 0.3 per share for Q3 2026.

0 Comments

Share your thoughts